Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Nov 18, 2024 12:08pm
79 Views
Post# 36318116

118% Surge in UK Cannabis Prescriptions

118% Surge in UK Cannabis Prescriptions

Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind.

After almost six years of medical cannabis being available on prescription in the UK, the numbers look promising. 

The sector has grown significantly in the last few years, with the CQC reporting a 118% increase in private prescriptions of unlicensed cannabis-based medicines between 2021-23. A separate FOI revealed 300,000 items were prescribed during this time and there are now thought to be upwards of 35,000 patients holding prescriptions in the UK.

But while patient numbers are undoubtedly increasing, there remains a huge knowledge gap when it comes to the level of awareness among healthcare professionals and the wider public. 

https://cannabishealthnews.co.uk/2024/10/24/118-surge-in-uk-cannabis-prescriptions-highlights-awareness-challenges/

<< Previous
Bullboard Posts
Next >>